色综合久久久中文综合_99热精品女神在线_亚洲综合套图欧美黄页网站_三年高清片大全_亚洲天堂国产精品视频_亚洲h图自拍偷拍_国语自产一区第二区三区_国产AV又大又粗又硬乱码_日韩成人毛片免费播放_欧美另类重口性

COMPANY PROFILE

New Milestones

Change, is for continuous innovation.

Xiamen Innodx was founded in August, 2013, with a registered capital of 200 million yuan.

It is a member of Yangshengtang Group.

It is the wholly-owned subsidiary of Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., and a high technology enterprise dedicating in chemilumine - scence immunoassay IVD reagent research and development, manufacturing, and sales.

200+

Product registration certificate

50+

Luminous research project

60+

CE certified products

97%

97% Coverage rate of sold products in all provinces

Domestic data are from Mainland China

COMPANY CULTURE

Enterprise Values

Innovation, excellence, hard work, win-win and responsibility

Corporate Vision

To present a super first-class comprehensive solution for in vitro diagnosis to users all over the world
Enterprise Mission

Contribute to the cause of human health
Enterprise Purpose

Quality for survival and scientific and technological innovation for development
Quality Policy

Science oriented and health oriented

Technique Support

In “National Institute of Diagnostics and Vaccine Development in Infectious Diseases (NIDVD)” co-founded by Yangshengtang and Xiamen University, it replies on its strong research and development, and establishes a reliable Acridinium Ester Fully Automated Chemiluminescence Immunoassay (CLIA) platform.

Technical Strength

It undertakes national 863 Plan, National Infectious Diseases Major Projects, the 12th Five-Year Plan and the 13th Five-Year Supporting Plan of Ministry of Science and Technology, and many provincial and municipal scientific research projects. It rapidly transforms scientific research achievements, and fast realizes the industrialization development.

Group Strucure

COMPANY HISTORY

2010

Initiated tubular Chemiluminescence Immunoassay (CLIA) platform.

2011

Finished tubular Chemiluminescence Immunoassay (CLIA) platform and self-developed Acridinium Ester Substrate System;
Undertook the 12th Five-Year 863 project.

2012

Initiated 90 kinds of reagent research and development.

2013

Established Wantai Innodx.

2014

Entered the stage of registration and application of chemiluminescence products.

2015

Came into the market with first product “Diagnostic Kit for Alpha-fetoprotein (Chemiluminescent Microparticle Immunoassay)”;
Established and put into production of new plant.

2016

Came into the market with 60 kinds of chemiluminescence products regarding to infectious diseases, tumor markers, and cardiac markers.

2017

Came into the market with star product “Diagnostic Kit for Specific Cellular Immune Response to Mycobacterium tubeiculosis”.

2018

Developed first Double Antigen Sandwich Method “Hepatitis B core antibody quantitative detection reagent” in global and entered the Innovative Medical Device Product List (2018); at the same time this index was taken into 2018 Canadian chronic hepatitis B Management Handbook.

2020

In March, first Double Antigen Sandwich Method “Novel coronavirus total antibody detection reagent” in global was approved and came into the market.

—

COMPANY HONORS

TypeYearsTitle

Award 2020Fujian New Research and Development Organization
Award 2020TUV ENISO 13485：2016 System Certification
Patent 2020Micro-fluidic chip control equipment, micro-fluidic control system, and micro-fluidic chip
Patent 2020Nucleic acid extraction device and nucleic acid extraction system
Patent 2020Chip clamp device and nucleic acid detection system
Patent 2020Micro-fluidic chip based fluorescence detection device and micro-fluidic chip detection system
Patent 2020Micro-fluidic chip puncture device and micro-fluidic chip detection system
Patent 2020Micro-fluidic chip module and micro-fluidic chip detection system
Patent 2020a kind of nucleic acid amplification reaction tube, reaction device and reagent (multiple countries) that can control fluid circulation path
Award 20192019 annual Big taxpayer
Award 2019Medical Device Institution Membership certificate
Award 2019New high-tech enterprise certificate
Award 2018Xiamen ‘Special, Fine, New’ small and micro enterprise
Patent 2018Micro-fluidic chip and biochemistry detection device
Patent 2018Micro-fluidic chip
Patent 2018Reagent storing modular, assembly of it and connected vessel, and micro-fluidic chip
Patent 2018Connected vessel, assembly of it with reagent modular, and micro-fluidic chip
Patent 2018Reaction chamber modular and micro-fluidic chip
Patent 2018Fluid guide value used for micro-fluidic chip and micro-fluidic chip
Patent 2018Method of extracting plasma from whole blood sample,blood filter, and micro-fluidic chip
Patent 2018Micro-fluidic chip, micro-fluidic system, and operating method
Award 2017Xiamen Scientific Little Giant Leading enterprise
Award 2017Infection series immune diagnosis reagent R&D and application, Xiamen Scientific and technological progress second award
Award 2016Excellent award of 5th China innovation venture contest (Xiamen area) and 2nd Egret Star innovation contest
Award 2016Finalist of 5th innovation venture contest
Patent 2016a kind of nucleic acid amplification reaction tube, reaction device and reagent (multiple countries) that can control fluid circulation path
Patent 2015Pratical and new type patent of a kind of magnetic seperation device
Patent 2015Hand-foot-and-mouth disease series immune diagnosis reagent R&D and application,Xiamen Scientific and technological progress second award
Award 2014Hand-foot-and-mouth disease series immune diagnosis reagent R&D and application,Xiamen Scientific and technological progress second award
Patent 2014Invention patent of a kind of acridinium ester enhanced chemiluminescence system
Award 2013Membership enterprise of 1st General Session of Fujian Medical Device Institution
Patent 2012Invention patent of Anti-HBC quantitative detection method and its usage on monitoring chronic hepatitis B patients' disease progression and predicting the treatment result
Patent 2011Invention patent of neutralizing epitope polypeptide of Enterovirus 71 and its usage

WeChat